High cost of new cancer drugs may lead to lower medical adherence

05/23/2011 | Wall Street Journal, The

Spending to treat cancer is likely to rise 15% annually through 2013, according to Medco's Drug Trend Report, primarily due to more expensive drugs. Some 10% of patients already fail to fill new prescriptions for oral cancer treatments, according to a study by Avalere Health and The West Clinic, and higher drug costs could lead to higher prescription abandonment rates. The study authors suggest that policymakers find ways to minimize out-of-pocket costs for low-income patients.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN